Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling

Ling Ding(Nebraska Medical Center), Bo Yang(Hangzhou Normal University)
Journal of Clinical Investigation
January 2, 2023
Cited by 74


Related Papers